+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhalation & Nasal Spray Generic Drugs Market - Global Forecast 2025-2030- Product Image
Inhalation & Nasal Spray Generic Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Inhalation & Nasal Spray Generic Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6125638
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The inhalation and nasal spray generic drugs market is undergoing rapid transformation, offering cost-effective respiratory therapies while meeting the demands of regulatory change, technological advancement, and diverse patient needs. Industry leaders are optimizing device design and leveraging collaborative approaches to remain competitive in a dynamic supply environment.

Market Snapshot: Inhalation and Nasal Spray Generics

This market is defined by the shift from branded respiratory products to generics, driven by the need to balance affordability with broad patient access. Advancements in device technology, regulatory scrutiny, and an increasing focus on patient-centric drug delivery have resulted in robust growth opportunities. With a comprehensive regulatory landscape and new digital health integrations, stakeholders are seeking strategically aligned partners to streamline manufacturing and ensure competitive supply chains.

Scope & Segmentation

The report delivers in-depth insight into the evolving inhalation and nasal spray generics market. The following segmentation outlines the full spectrum of current offerings and future directions:

  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
  • Product Types: Dry powder inhalers (capsule-based, reservoir-based), metered dose inhalers (multi-dose, single dose), nasal spray, nebulizer solutions
  • Therapeutic Classes: Anti-allergic, bronchodilators (anticholinergics, long- and short-acting bronchodilators), corticosteroids, mucolytics
  • Applications: Allergic rhinitis (perennial, seasonal), asthma (adult, pediatric), COPD (chronic bronchitis, emphysema)
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Teva Pharmaceutical Industries Ltd, Sandoz AG, Viatris Inc, Perrigo Company plc, Fresenius Kabi AG, Cipla Limited, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Hikma Pharmaceuticals plc

Innovations highlighted include smart inhalers, modular device platforms, and propellant alternatives developed to address sustainability and usability. Growth in domestic manufacturing, cross-border regulatory harmonization, and tailored supply chain models are also explored regionally.

Key Takeaways: Strategic Insights for Decision-Makers

  • Regulatory agencies are raising the bar on device compatibility and formulation equivalence, prompting sustained investment in device testing and quality assurance.
  • Digital tools, such as smart inhaler integration, are enhancing real-time adherence monitoring, resulting in improved patient outcomes and deeper payer engagement.
  • Partnerships between manufacturers, contract organizations, and suppliers enable rapid innovation and adaptation to localized procurement needs.
  • Supply chain models are shifting toward regionalization against the backdrop of global trade uncertainty, optimizing response times and reducing overreliance on overseas routes.
  • Sustainability is gaining traction, with key players developing novel carriers and eco-friendly packaging to meet evolving environmental standards.
  • Therapeutic class differentiation—such as the rising demand for anti-allergic agents and long-acting bronchodilators—guides targeted development and commercialization strategies across hospital, retail, and online channels.

Tariff Impact: Navigating the 2025 US Trade Shift

Tariffs imposed in the United States in 2025 have escalated import costs for core drug substances and device components. Manufacturers have adapted by realigning their sourcing strategies, prioritizing suppliers from regions with fewer trade barriers, and investing in domestic automation to buffer against future trade volatility. Distribution models and logistics are being recalibrated, resulting in greater supply chain agility and enhanced risk management protocols.

Methodology & Data Sources

This analysis is based on a hybrid methodology that combines primary interviews with industry and regulatory experts, survey feedback from healthcare providers, and exhaustive review of regulatory, scientific, and trade data. Triangulation with subject-matter specialists ensures accuracy and relevance.

Why This Report Matters

  • Provides actionable intelligence for developing compliant, patient-centric, and resilient product portfolios in inhalation and nasal spray generics.
  • Offers strategic guidance to enhance operational agility, minimize tariff exposure, and leverage partnerships for accelerated innovation.
  • Enables informed long-term planning by mapping emerging regulatory, technology, and supply chain trends with precision.

Conclusion

Organizations looking to excel in inhalation and nasal spray generics will benefit from integrating insights on technology, regulation, and regional market dynamics. By acting on the recommendations detailed herein, leaders can fortify their competitive positions and sustainably address the evolving needs of respiratory therapy markets.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expanding competition among pharmaceutical companies for ready-to-use multidose inhaler generic approvals
5.2. Adoption of novel propellant systems to enhance lung deposition in generic metered dose inhalers
5.3. Increasing investments in bioequivalence study innovations for complex nasal spray generics
5.4. Growth of contract development and manufacturing partnerships for preservative-free nasal formulations
5.5. Surging demand for cost-effective generic biologic inhalation therapies following patent expirations
5.6. Implementation of advanced spray pattern analytics to ensure consistency across generic nasal products
5.7. Regulatory focus on demonstrating equivalence in regional deposition for generic dry powder inhalers
5.8. Integration of digital dose counters into generic inhalers to improve patient adherence and monitoring
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Inhalation & Nasal Spray Generic Drugs Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Inhalation & Nasal Spray Generic Drugs Market, by Product Type
9.1. Introduction
9.2. Dry Powder Inhaler
9.2.1. Capsule Based
9.2.2. Reservoir Based
9.3. Metered Dose Inhaler
9.3.1. Multi Dose Inhaler
9.3.2. Single Dose Inhaler
9.4. Nasal Spray
9.5. Nebulizer Solution
10. Inhalation & Nasal Spray Generic Drugs Market, by Therapeutic Class
10.1. Introduction
10.2. Anti Allergic
10.3. Bronchodilators
10.3.1. Anticholinergics
10.3.2. Long Acting Bronchodilators
10.3.2.1. Formoterol
10.3.2.2. Salmeterol
10.3.3. Short Acting Bronchodilators
10.3.3.1. Albuterol
10.3.3.2. Levalbuterol
10.4. Corticosteroids
10.5. Mucolytics
11. Inhalation & Nasal Spray Generic Drugs Market, by Application
11.1. Introduction
11.2. Allergic Rhinitis
11.2.1. Perennial Allergic Rhinitis
11.2.2. Seasonal Allergic Rhinitis
11.3. Asthma
11.3.1. Adult Asthma
11.3.2. Pediatric Asthma
11.4. CObD
11.4.1. Chronic Bronchitis
11.4.2. Emphysema
12. Americas Inhalation & Nasal Spray Generic Drugs Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Inhalation & Nasal Spray Generic Drugs Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Teva Pharmaceutical Industries Ltd
15.3.2. Sandoz AG
15.3.3. Viatris Inc
15.3.4. Perrigo Company plc
15.3.5. Fresenius Kabi AG
15.3.6. Cipla Limited
15.3.7. Dr. Reddy's Laboratories Ltd
15.3.8. Sun Pharmaceutical Industries Ltd
15.3.9. Lupin Limited
15.3.10. Hikma Pharmaceuticals plc
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. INHALATION & NASAL SPRAY GENERIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. INHALATION & NASAL SPRAY GENERIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. INHALATION & NASAL SPRAY GENERIC DRUGS MARKET: RESEARCHAI
FIGURE 24. INHALATION & NASAL SPRAY GENERIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 25. INHALATION & NASAL SPRAY GENERIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 26. INHALATION & NASAL SPRAY GENERIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY CAPSULE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY CAPSULE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY RESERVOIR BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY RESERVOIR BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY MULTI DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY MULTI DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SINGLE DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SINGLE DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY NASAL SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY NEBULIZER SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY NEBULIZER SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ANTI ALLERGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ANTI ALLERGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY FORMOTEROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY FORMOTEROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SALMETEROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SALMETEROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALBUTEROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALBUTEROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LEVALBUTEROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LEVALBUTEROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PERENNIAL ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PERENNIAL ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ADULT ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ADULT ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PEDIATRIC ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PEDIATRIC ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY EMPHYSEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY EMPHYSEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 152. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 153. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 154. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 155. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 156. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 157. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 158. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 159. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 160. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 161. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 162. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 163. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2024 (USD MILLION)
TABLE 166. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2025-2030 (USD MILLION)
TABLE 167. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2024 (USD MILLION)
TABLE 168. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2025-2030 (USD MILLION)
TABLE 169. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2018-2024 (USD MILLION)
TABLE 170. CANADA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2025-2030 (USD MILLION)
TABLE 171. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 177. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 179. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2024 (USD MILLION)
TABLE 192. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2025-2030 (USD MILLION)
TABLE 193. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2018-2024 (USD MILLION)
TABLE 194. MEXICO INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY LONG ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY SHORT ACTING BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COBD, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM INHALATION & NASAL SPRAY GENERIC DRUGS MARKET SIZE, BY DRY POWDER

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Inhalation & Nasal Spray Generic Drugs market report include:
  • Teva Pharmaceutical Industries Ltd
  • Sandoz AG
  • Viatris Inc
  • Perrigo Company plc
  • Fresenius Kabi AG
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Limited
  • Hikma Pharmaceuticals plc

Related Topics

Related Reports

Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report - Product Image

Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Inhalation and Nasal Spray Generic Drugs Market Report 2025 - Product Image

Inhalation and Nasal Spray Generic Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Nasal Spray Market Overview, 2025-30 - Product Image

Nasal Spray Market Overview, 2025-30

  • Report
  • 115 Pages
  • Global
From
Nasal Spray Market Outlook, 2030 - Product Image

Nasal Spray Market Outlook, 2030

  • Report
  • 203 Pages
  • Global
From
Mometasone Furoate Aqueous Nasal Spray Market - Global Forecast 2025-2030 - Product Image

Mometasone Furoate Aqueous Nasal Spray Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.